News from ebrain
Category: Industry News
New Rehabilitation Prescription – RP2019 now available
New Rehabilitation Prescription now available
Australian medicinal cannabis company Althea to launch in UK
News from Althea
ACNR announces new partnership with Taylor & Francis
20% book discount offer from Taylor & Francis
Christchurch Group announces appointment of Donald Muir as Non-Executive Chairman
News from The Christchurch Group
NHS England will fund everolimus for TSC-related refractory epilepsy
News from the Tuberous Sclerosis Association
People in Scotland get access to new first-in-class treatment Ocrevus®▼(ocrelizumab) for multiple sclerosis
News from industry: Roche
Encephalitis Society Silver Jubilee PhD Fellowship 2019 – Host academic Institution sought
The Encephalitis Society are seeking an academic institution to host the 2019 Encephalitis Society PhD Fellowship. Deadline: Monday, December 31, 2018
Emgality® (galcanezumab) Receives European Commission Approval for the Prophylaxis of Migraine in Adults
New migraine treatment from Lilly receives approval from European Commission
